Position in VERU
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$234,164
+$67,833 QoQ
Shares Held
74,813
-0.6% QoQ
Ownership
0.439%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 61 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VERU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $19,777,074 across 42 Biotechnology names. VERU ranks #28 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,514 | $3,438,199 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,474 | $3,215,830 | |
| 3 | INCY |
Incyte Corp
|
7,759 | $879,560 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,770 | $833,853 | |
| 5 | ARGX |
Argenx SE
|
809 | $750,565 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,045 | $733,753 | |
| 7 | TWST |
Twist Bioscience Corp
|
6,969 | $716,970 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
27,134 | $686,490 |
All Filings in VERU
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $234,164 | 74,813 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $166,331 | 75,263 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $161,204 | 75,329 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $286,778 | 75,468 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $327,945 | 669,277 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $259,855 | 399,777 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $241,928 | 314,193 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $278,922 | 332,050 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $64,341 | 91,916 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||